CELEX: 62016TA0662
Language: en
Date: 2018-05-03 00:00:00
Title: Case T-662/16: Judgment of the General Court of 3 May 2018 — Gall Pharma v EUIPO — Pfizer (Styriagra) (EU trade mark — Opposition proceedings — Application for EU word mark Styriagra — Earlier EU word mark VIAGRA — Taking unfair advantage of the distinctive character or repute of the earlier mark — Article 8(5) of Regulation (EC) No 207/2009 (now Article 8(5) of Regulation (EU) 2017/1001))

201806080161931422018/C 221/206622016TC22120180625EN01ENINFO_JUDICIAL20180503181811Case T-662/16: Judgment of the General Court of 3 May 2018 — Gall Pharma v EUIPO — Pfizer (Styriagra) (EU trade mark — Opposition proceedings — Application for EU word mark Styriagra — Earlier EU word mark VIAGRA — Taking unfair advantage of the distinctive character or repute of the earlier mark — Article 8(5) of Regulation (EC) No 207/2009 (now Article 8(5) of Regulation (EU) 2017/1001))
 ---documentbreak--- C2212018EN1810120180503EN0020181181Judgment of the General Court of 3 May 2018 — Gall Pharma v EUIPO — Pfizer (Styriagra)
   (Case T-662/16) (
         1
      )
   ‛(EU trade mark — Opposition proceedings — Application for EU word mark Styriagra — Earlier EU word mark VIAGRA — Taking unfair advantage of the distinctive character or repute of the earlier mark — Article 8(5) of Regulation (EC) No 207/2009 (now Article 8(5) of Regulation (EU) 2017/1001))’2018/C 221/20Language of the case: English
      Parties
   
   
      Applicant: Gall Pharma GmbH (Judenburg, Austria) (represented initially by: D. Reichelt and L. Figura, and subsequently by T. Schafft, lawyers)
   
      Defendant: European Union Intellectual Property Office (represented by: D. Gája and D. Walicka, acting as Agents)
   
      Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Pfizer Inc. (New York, New York, United States) (represented by: V. von Bomhard and J. Fuhrmann, lawyers)
   
      Re:
   
   Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 June 2016 (Case R 724/2015-5), relating to opposition proceedings between Pfizer and Gall Pharma.
   
      Operative part of the judgment
   
   The Court:
   
            1.
         
         
            Dismisses the action;
         
      
            2.
         
         
            Orders Gall Pharma GmbH to pay the costs.
         
      (
         1
      )	OJ C 441, 28.11.2016.